Quoin Pharmaceuticals Ltd. (QNRX)
6.93
-0.04
(-0.57%)
USD |
NASDAQ |
Sep 10, 16:00
6.93
0.00 (0.00%)
After-Hours: 16:25
Quoin Pharmaceuticals EPS Diluted (Quarterly) : -2.720 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.720 |
| March 31, 2026 | -2.541 |
| December 31, 2025 | -2.920 |
| September 30, 2025 | -6.744 |
| June 30, 2025 | -224.52 |
| March 31, 2025 | -226.32 |
| December 31, 2024 | -437.19 |
| September 30, 2024 | -0.4714 |
| June 30, 2024 | -0.3886 |
| March 31, 2024 | -1.122 |
| December 31, 2023 | -2.099 |
| September 30, 2023 | -1.945 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | -0.0001 |
| September 30, 2022 | -0.0001 |
| June 30, 2022 | -0.0005 |
| March 31, 2022 | -0.0005 |
| December 31, 2021 | -0.0035 |
| September 30, 2021 | -0.0036 |
| June 30, 2021 | -2665.36 |
| March 31, 2021 | -0.1314 |
| December 31, 2020 | -628.05 |
| September 30, 2020 | -621.81 |
| June 30, 2020 | -0.0069 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0023 |
| December 31, 2019 | -0.0078 |
| September 30, 2019 | -0.0061 |
| June 30, 2019 | -0.001 |
| March 31, 2019 | -0.0079 |
| December 31, 2018 | -0.0078 |
| September 30, 2018 | -0.0144 |
| June 30, 2018 | -0.0129 |
| March 31, 2018 | -0.0081 |
| December 31, 2017 | -0.008 |
| September 30, 2017 | -0.0197 |
| June 30, 2017 | -0.0118 |
| March 31, 2017 | -0.0372 |
| December 31, 2016 | -0.007 |
| September 30, 2016 | -53118.22 |
| June 30, 2016 | -0.0102 |
| March 31, 2016 | -0.0127 |
| December 31, 2015 | -0.0126 |
| September 30, 2015 | -0.0085 |
| June 30, 2015 | -0.0073 |
| March 31, 2015 | -0.0066 |
| December 31, 2014 | -0.0067 |
| September 30, 2014 | -0.0065 |
| June 30, 2014 | -0.0061 |
| March 31, 2014 | -0.0034 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.463M |
| Total Expenses (Quarterly) | 5.463M |
| Enterprise Value | 3.198M |
| Earnings Yield | -215.4% |
| Normalized Earnings Yield | -215.49 |